Our passion for making a difference unites us.
Amicus Therapeutics is a global, patient-dedicated biotech focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic
Living with CDKL5 Deficiency Disorder
We are a biotechnology company at the forefront of advanced therapies to treat a range of devasting rare diseases.
Extraordinary Patient Focus
At Amicus, patient-centricity is in our DNA. See how our commitment to patients goes further than just our medicines and expands out to the rare disease community at large.